TechCrunch
plus-bold
TechCrunch
Open Navigation
TechCrunch
Eligo Bioscience
Eligo Bioscience raises $20 million to target the microbiome more precisely
Sep 26, 2017
Romain Dillet
French startup Eligo Bioscience just raised $20 million to develop next-gen biotherapeutics. Khosla Ventures is leading the round. This is also Khosla Ventures’ first investment in a French startup.